King's College London

Research portal

Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis

Research output: Contribution to journalArticle

Maria U. Moreno, Idoia Gallego, Begona Lopez, Arantxa Gonzalez, Ana Fortuno, Gorka San Jose, Felix Valencia, Juan Jose Gomez-Doblas, Eduardo de Teresa, Ajay M. Shah, Javier Diez, Guillermo Zalba

Original languageEnglish
Article numberN/A
Pages (from-to)291-300
Number of pages10
JournalClinical Science
Issue number5-6
Publication statusPublished - Sep 2013

King's Authors


The NADPH oxidases are a key family of ROS (reactive oxygen species)-producing enzymes which may differentially contribute to cardiac pathophysiology. Animal studies show uncertain results regarding the regulation of cardiac Nox4 by pressure overload and no data are available on human myocardial Nox4. In the present study, we evaluated Nox4 expression and its relationship with myocardial remodelling and LV (left ventricular) function in patients with severe AS (aortic valve stenosis). Endomyocardial biopsies from 34 patients with AS were obtained during aortic valve replacement surgery. LV morphology and function were assessed by echocardiography. Myocardial samples from subjects deceased of non-CVDs (cardiovascular diseases) were analysed as controls. Nox4 localization was evaluated by immunohistochemistry and quantified by Western blot. Myocardial capillary density, fibrosis and cardiomyocyte dimensions and apoptosis were assessed histologically to evaluate myocardial remodelling. Nox4 was present in samples from all subjects and expressed in cardiomyocytes, VSMCs (vascular smooth muscle cells), endothelium and fibroblasts. Nox4 levels were reduced 5-fold in AS patients compared with controls (P <0.01). Nox4 levels directly correlated with cardiomyocyte cross-sectional area (r = 0.299, P <0.05) and diameter (r = 0.406, P <0.05) and capillary density (r = 0.389, P <0.05), and inversely with cardiomyocyte apoptosis (r = -0.316, P <0.05) in AS patients. In addition, Nox4 levels correlated with echocardiographic parameters (LV ejection fraction: r = 0.353, P <0.05; midwall fractional shortening: r = 0.355, P <0.05; deceleration time: r = -0.345, P <0.05) in AS patients. Nox4 is expressed in human myocardium and reduced in AS patients. The observed associations of Nox4 with cardiomyocyte parameters and capillary density in AS patients suggest a potential role of Nox4 deficiency in the myocardial remodelling present in the human pressure-overloaded heart.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454